3.44
price up icon3.61%   0.12
after-market Dopo l'orario di chiusura: 3.44
loading

Lipocine Inc Borsa (LPCN) Ultime notizie

pulisher
Jul 25, 2025

What analysts say about Lipocine Inc. stockHigh-impact stock picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Lipocine Inc. stock priceUnstoppable investment returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

How Lipocine Inc. stock performs during market volatilityDaily Stock Radar - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

Is Lipocine Inc. a good long term investmentFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Lipocine Inc. Stock Analysis and ForecastSpectacular growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

What makes Lipocine Inc. stock price move sharplyTrade With Low Risk Exposure - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Lipocine Inc. stock attracts strong analyst attentionStable Growth Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Lipocine stock maintains Buy rating at H.C. Wainwright on PPD treatment potential - Investing.com Australia

Jul 11, 2025
pulisher
Jun 30, 2025

Lipocine stock maintains Buy rating at H.C. Wainwright as Phase 3 trial begins - Investing.com

Jun 30, 2025
pulisher
Jun 27, 2025

First Patient Receives Lipocene's LPCN 1154 for Postpartum Depression in Phase 3 Clinical Trial - Patient Care Online

Jun 27, 2025
pulisher
Jun 26, 2025

LPCN Begins Pivotal Phase 3 Trial for Postpartum Depression Treatment | LPCN Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression - Financial Times

Jun 26, 2025
pulisher
Jun 23, 2025

Lipocine to Host R&D Event on July 9 - TipRanks

Jun 23, 2025
pulisher
Jun 12, 2025

HC Wainwright Estimates Lipocine’s Q1 Earnings (NASDAQ:LPCN) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Lipocine (NASDAQ:LPCN) Given Buy Rating at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

LPCN Stock Maintains 'Buy' Rating with $8.00 Price Target | LPCN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Lipocine partner files for Canadian approval of oral TRT drug By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Verity Pharma Files TLANDO Drug Submission In Canada For Lipocine - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

LPCN: Lipocine's TRT Submission in Canada Marks Key Milestone | - GuruFocus

Jun 09, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):